APOLLOHOSP - Apollo Hospitals Enterprises Ltd. Share Price

Healthcare Services

₹7831.00+9.50(+0.12%)

Market Closed as of Aug 18, 2025, 15:30 IST

Select time range

Valuation
Market Cap	1.06 LCr
Price/Earnings (Trailing)	73.11
Price/Sales (Trailing)	4.81
EV/EBITDA	34.26
Price/Free Cashflow	249.48
MarketCap/EBT	52.69
Enterprise Value	1.1 LCr

Fundamentals
Revenue (TTM)	21.99 kCr
Rev. Growth (Yr)	13.7%
Earnings (TTM)	1.51 kCr
Earnings Growth (Yr)	60.4%

Profitability
Operating Margin	9%
EBT Margin	9%
Return on Equity	17.39%
Return on Assets	7.29%
Free Cashflow Yield	0.40%

Price to Sales Ratio

Latest reported: 5

Revenue (Last 12 mths)

Latest reported: 22 kCr

Net Income (Last 12 mths)

Latest reported: 2 kCr

Growth & Returns
Price Change 1W	-2.4%
Price Change 1M	-3.7%
Price Change 6M	5.9%
Price Change 1Y	8.8%
3Y Cumulative Return	18.5%
5Y Cumulative Return	33.9%
7Y Cumulative Return	33.4%
10Y Cumulative Return	17.6%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-3.38 kCr
Cash Flow from Operations (TTM)	2.14 kCr
Cash Flow from Financing (TTM)	1.32 kCr
Cash & Equivalents	578.1 Cr
Free Cash Flow (TTM)	423.7 Cr
Free Cash Flow/Share (TTM)	29.47

Balance Sheet
Total Assets	20.66 kCr
Total Liabilities	12 kCr
Shareholder Equity	8.65 kCr
Current Assets	7.03 kCr
Current Liabilities	4.58 kCr
Net PPE	9.82 kCr
Inventory	480.8 Cr
Goodwill	1.03 kCr

Capital Structure & Leverage
Debt Ratio	0.26
Debt/Equity	0.61
Interest Coverage	3.38
Interest/Cashflow Ops	5.66

Dividend & Shareholder Returns
Dividend/Share (TTM)	19
Dividend Yield	0.26%
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	0.00%

Risk & Volatility
Max Drawdown	-3.5%
Drawdown Prob. (30d, 5Y)	30.77%
Risk Level (5Y)	29.8%

Pros

Growth: Good revenue growth. With 49.2% growth over past three years, the company is going strong.

Balance Sheet: Strong Balance Sheet.

Technicals: Bullish SharesGuru indicator.

Smart Money: Smart money has been increasing their position in the stock.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Past Returns: In past three years, the stock has provided 18.5% return compared to 12.3% by NIFTY 50.

Size: It is among the top 200 market size companies of india.

Cons

Momentum: Stock is suffering a negative price momentum. Stock is down -3.7% in last 30 days.

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Rank

Balance Sheet

Momentum

Technicals

Smart Money

Insider Trading

Investor Care
Dividend Yield	0.26%
Dividend/Share (TTM)	19
Shares Dilution (1Y)	0.00%
Earnings/Share (TTM)	100.56

Financial Health
Current Ratio	1.54
Debt/Equity	0.61

Technical Indicators
RSI (14d)	45.48
RSI (5d)	17.45
RSI (21d)	38.23
MACD Signal	Sell
Stochastic Oscillator Signal	Hold
Grufity Signal	Buy
RSI Signal	Hold
RSI5 Signal	Buy
RSI21 Signal	Hold
SMA 5 Signal	Sell
SMA 10 Signal	Sell
SMA 20 Signal	Sell
SMA 50 Signal	Buy
SMA 100 Signal	Buy

Latest News and Updates from Apollo Hospitals Enterprises

Updated May 4, 2025

The Bad News

Source-Mint

The stock is trading 0.55% lower and has seen a year-to-date decline of 4.38%.

Source-Mint

Mutual fund and foreign institutional investor holdings have decreased to 12.77% and 45.27%, respectively.

Source-Mint

The company's TTM P/E ratio of 80.08 is significantly higher than the sector average of 23.01, raising concerns about its valuation.

The Good News

Source-The Financial Express

Apollo Hospitals Enterprise has shown a robust five-year performance with an increase of 406.03%.

Source-The Financial Express

The stock has demonstrated a monthly return of 5.17%, indicating some recovery in recent weeks.

Source-Mint

Among 24 analysts, 21 recommend a buy or strong buy for the stock, reflecting a level of confidence in its long-term prospects.

Updates from Apollo Hospitals Enterprises

General • 01 Aug 2025

As per annexure enclosed

Analyst / Investor Meet • 29 Jul 2025

As per annexure enclosed

Analyst / Investor Meet • 08 Jul 2025

as per annexure enclosed

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 • 08 Jul 2025

Certificate under Regulation 74(5) for the period ended 30th June 2025 enclosed

Analyst / Investor Meet • 01 Jul 2025

as per annexure enclosed

Analyst / Investor Meet • 01 Jul 2025

as per annexure enclosed

Analyst / Investor Meet • 30 Jun 2025

As per annexure enclosed

This information is AI-generated and may contain inaccuracies. Please verify from multiple sources.

Summary of Latest Earnings Report from Apollo Hospitals Enterprises

Summary of Apollo Hospitals Enterprises's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.

Earnings Outlook

Last updated:

Q&A Session

Last updated:

Revenue Breakdown

Analysis of Apollo Hospitals Enterprises's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.

Revenue

Last Updated: Mar 31, 2025

Description	Share	Value
Healthcare services	50.6%	2.8 kCr
Digital health & pharmacy distribution	42.3%	2.4 kCr
Retail health & diagnostics	7.0%	394 Cr
Total		5.6 kCr

Share Holdings

Understand Apollo Hospitals Enterprises ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

Shareholder Name	Holding %
M/s. PCR Investments Ltd	18.93%
Ms. Suneeta Reddy	3.36%
MIRAE ASSET MIDCAP FUND	2.21%
Ms. Sangita Reddy	1.69%
HDFC TRUSTEE COMPANY LIMITED	1.62%
Ms. Shobana Kamineni	1.56%
GOVERNMENT OF SINGAPORE	1.49%
SBI NIFTY 50 ETF	1.45%
AXIS MUTUAL FUND TRUSTEE LIMITED	1.27%
INVESCO INDIA CONTRA FUND	1.23%
NIPPON LIFE INDIA TRUSTEE LTD	1.2%
GOVERNMENT PENSION FUND GLOBAL	1.14%
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED	1.14%
FRANKLIN INDIA FLEXI CAP FUND	1.12%
Mr. K Vishweshwar Reddy	1.1%
SCHRODER INTERNATIONAL SELECTION FUND ASIAN OPPORTUNITIES	1.03%
KOTAK FUNDS - INDIA MIDCAP FUND	1.02%
Ms. Preetha Reddy	0.73%
Mr. Karthik Anand	0.24%
Mr. Harshad Reddy	0.23%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Is Apollo Hospitals Enterprises Better than it's peers?

Detailed comparison of Apollo Hospitals Enterprises against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
MAXHEALTH	Max Healthcare Institute	1.24 LCr	7.18 kCr	-1.90%	+47.10%	115.08	17.24	-	-
FORTIS	Fortis Healthcare	65.39 kCr	7.85 kCr	+7.30%	+72.60%	84.42	8.33	-	-
NH	Narayana Hrudayalaya	36.94 kCr	5.84 kCr	-10.10%	+47.90%	46.74	6.32	-	-
MEDANTA	Global Health	35.64 kCr	3.77 kCr	+12.10%	+15.20%	74.04	9.45	-	-
KIMS	Krishna Institute of Medical Sciences	29.64 kCr	3.07 kCr	+8.00%	+77.70%	77.12	9.66	-	-
LALPATHLAB	Dr. Lal Pathlabs	26.62 kCr	2.63 kCr	+12.00%	+1.00%	51.6	10.12	-	-
METROPOLIS	Metropolis Healthcare	10.49 kCr	1.35 kCr	+14.20%	-1.40%	71.57	7.79	-	-

Sector Comparison: APOLLOHOSP vs Healthcare Services

Comprehensive comparison against sector averages

Comparative Metrics

APOLLOHOSP metrics compared to Healthcare

Category	APOLLOHOSP	Healthcare
PE	73.11	73.50
PS	4.81	7.38
Growth	14.8 %	3.6 %

Performance Comparison

APOLLOHOSP vs Healthcare (2021 - 2025)

Key Insights

1. APOLLOHOSP is among the Top 3 Hospital companies by market cap.
2. The company holds a market share of 33.2% in Hospital.
3. In last one year, the company has had an above average growth that other Hospital companies.

Income Statement for Apollo Hospitals Enterprises

Consolidated figures (in Rs. Crores) / View Standalone Data

AnnualQuarterly

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	14.4%	21,794	19,059	16,612	14,663	10,560	11,247
Other Income	89.5%	200	106	90	78	45	27
Total Income	14.8%	21,994	19,166	16,703	14,741	10,605	11,274
Cost of Materials	12.2%	2,754	2,454	2,284	2,685	1,623	1,809
Purchases of stock-in-trade	15.9%	8,557	7,385	6,315	4,961	4,186	3,797
Employee Expense	11%	2,769	2,494	2,144	1,787	1,601	1,853
Finance costs	2%	458	449	381	379	449	533
Depreciation and Amortization	10.3%	758	687	615	601	573	620
Other expenses	7.4%	4,693	4,369	3,845	3,118	2,137	2,308
Total Expenses	12.3%	19,988	17,805	15,559	13,457	10,445	10,812
Profit Before exceptional items and Tax	47.4%	2,006	1,361	1,144	1,284	160	462
Exceptional items before tax	-211.1%	0	1.9	0	294	61	198
Total profit before tax	47.3%	2,006	1,362	1,144	1,578	221	660
Current tax	20.4%	526	437	406	238	76	214
Deferred tax	-13%	7.7	8.7	-149.67	239	8.92	11
Total tax	19.8%	534	446	256	477	85	225
Total profit (loss) for period	61%	1,505	935	845	1,108	137	432
Other comp. income net of taxes	36%	-6.3	-10.4	-13.27	-9.72	15	-0.6
Total Comprehensive Income	62.1%	1,499	925	831	1,099	152	431
Earnings Per Share, Basic	61.9%	100.56	62.5	56.97	73.42	10.74	32.7
Earnings Per Share, Diluted	61.9%	100.56	62.5	56.97	73.42	10.74	32.7

Description	(%) Q/Q	Mar-2025	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023
Revenue From Operations	1.2%	5,592	5,527	5,589	5,086	4,944	4,851
Other Income	-4.8%	61	64	38	37	28	28
Total Income	1.1%	5,653	5,591	5,628	5,123	4,972	4,878
Cost of Materials	10.9%	694	626	744	690	638	603
Purchases of stock-in-trade	-2.1%	2,244	2,292	2,110	1,911	1,914	1,944
Employee Expense	5.7%	725	686	700	658	645	613
Finance costs	4.6%	115	110	118	116	119	113
Depreciation and Amortization	14.1%	211	185	184	177	190	167
Other expenses	-0.8%	1,169	1,178	1,216	1,129	1,113	1,091
Total Expenses	1.7%	5,148	5,060	5,076	4,704	4,612	4,516
Profit Before exceptional items and Tax	-4.9%	505	531	552	418	360	362
Exceptional items before tax	-	0	0	0	0	0	0
Total profit before tax	-4.9%	505	531	552	418	360	362
Current tax	-11.3%	119	134	160	113	89	113
Deferred tax	-190.5%	-18	22	1.9	1.5	21	-4.3
Total tax	-35.9%	101	157	162	114	110	109
Total profit (loss) for period	9.3%	414	379	396	316	258	254
Other comp. income net of taxes	-2.6%	-3	-2.9	-5.5	5.2	-0.2	0.8
Total Comprehensive Income	9.6%	412	376	390	321	258	255
Earnings Per Share, Basic	4.9%	27.1	25.89	26.34	21.23	17.65	17.06
Earnings Per Share, Diluted	4.9%	27.1	25.89	26.34	21.23	17.65	17.06

Standalone figures (in Rs. Crores) / View Consolidated Data

AnnualQuarterly

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	12.8%	8,202	7,274	6,525	6,098	9,153	9,794
Other Income	93.9%	348	180	152	47	18	11
Total Income	14.7%	8,550	7,454	6,676	6,145	9,171	9,805
Cost of Materials	12.5%	2,248	1,999	1,861	1,929	1,330	1,532
Purchases of stock-in-trade	-	0	0	0	0	4,155	3,754
Employee Expense	12.1%	1,597	1,425	1,239	1,150	1,275	1,519
Finance costs	1.6%	254	250	239	244	344	426
Depreciation and Amortization	12.6%	449	399	367	363	436	482
Other expenses	12.7%	2,313	2,052	1,743	1,599	1,573	1,678
Total Expenses	12%	6,861	6,125	5,449	5,286	8,985	9,287
Profit Before exceptional items and Tax	27%	1,688	1,329	1,228	859	186	518
Exceptional items before tax	-	0	0	0	-6.74	-9.09	164
Total profit before tax	27%	1,688	1,329	1,228	852	177	682
Current tax	26.2%	406	322	302	40	62	205
Deferred tax	-217.8%	-13.3	-3.5	-159.77	239	9.48	6.94
Total tax	23.3%	392	318	143	280	72	212
Total profit (loss) for period	28.3%	1,296	1,010	1,085	665	105	470
Other comp. income net of taxes	91.6%	0.2	-8.5	-11.14	-2.24	-5.58	0.75
Total Comprehensive Income	29.4%	1,296	1,002	1,074	663	100	471
Earnings Per Share, Basic	28.7%	90.15	70.28	75.45	46.26	7.51	33.8
Earnings Per Share, Diluted	28.7%	90.15	70.28	75.45	46.26	7.51	33.8
Debt equity ratio	-	-	-	025	-	082	082
Debt service coverage ratio	-	-	-	0.0231	-	0.0292	0.0292
Interest service coverage ratio	-	-	-	0.0713	-	0.0427	0.0427

Description	(%) Q/Q	Mar-2025	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023
Revenue From Operations	1%	2,075	2,055	2,135	1,937	1,895	1,824
Other Income	-15%	92	108	121	27	46	52
Total Income	0.2%	2,167	2,163	2,256	1,964	1,941	1,876
Cost of Materials	-1.2%	562	569	581	536	527	496
Employee Expense	4.1%	410	394	412	381	384	350
Finance costs	1.6%	63	62	65	64	69	61
Depreciation and Amortization	20.6%	130	108	108	103	115	97
Other expenses	0.3%	582	580	602	549	534	527
Total Expenses	2%	1,747	1,713	1,769	1,632	1,628	1,532
Profit Before exceptional items and Tax	-6.5%	420	449	488	332	312	344
Total profit before tax	-6.5%	420	449	488	332	312	344
Current tax	-5.8%	99	105	120	81	54	90
Deferred tax	-950%	-12.6	2.6	-2.2	-1.1	19	-8.8
Total tax	-19.6%	87	108	118	80	74	81
Total profit (loss) for period	-2.6%	333	342	370	252	239	263
Other comp. income net of taxes	74.3%	0.1	-2.5	-2.4	5	0.3	0.8
Total Comprehensive Income	-1.5%	334	339	367	257	239	264
Earnings Per Share, Basic	-2.5%	23.18	23.76	25.71	17.51	16.61	18.28
Earnings Per Share, Diluted	-2.5%	23.18	23.76	25.71	17.51	16.61	18.28
Debt equity ratio	-	-	-	-	-	-	024
Debt service coverage ratio	-	-	-	-	-	-	0.0419
Interest service coverage ratio	-	-	-	-	-	-	0.0696

Balance Sheet for Apollo Hospitals Enterprises

Consolidated figures (in Rs. Crores) / View Standalone Data

Description	(%) Q/Q	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022
Cash and cash equivalents	-59.8%	578	1,435	506	472	433	562
Current investments	105.3%	1,432	698	684	562	292	325
Loans, current	105%	5.1	3	4.9	5.67	5.63	6.08
Total current financial assets	-8%	5,996	6,514	4,304	4,117	3,602	3,621
Inventories	7.4%	481	448	460	423	390	436
Current tax assets	-	0	-	-	252	-	214
Total current assets	-4.2%	7,029	7,338	5,280	5,140	4,337	4,567
Property, plant and equipment	8.5%	9,816	9,043	8,540	7,771	7,432	7,209
Capital work-in-progress	-26%	771	1,042	845	727	602	548
Investment property	-14.3%	2.8	3.1	3.4	3.75	4.06	4.37
Goodwill	1.8%	1,030	1,012	1,012	1,011	986	952
Non-current investments	164.9%	830	314	104	290	96	101
Loans, non-current	-13.3%	27	31	6.6	6.9	8.37	6.08
Total non-current financial assets	70.2%	1,070	629	363	614	401	266
Total non-current assets	11.6%	13,628	12,210	11,473	10,421	10,091	9,408
Total assets	5.7%	20,657	19,548	16,753	15,561	14,428	13,975
Borrowings, non-current	15.7%	4,417	3,819	2,236	2,016	1,938	2,311
Total non-current financial liabilities	12.8%	6,862	6,081	4,227	4,409	4,052	4,260
Provisions, non-current	10%	89	81	73	56	57	55
Total non-current liabilities	12%	7,426	6,632	4,768	4,904	4,572	4,720
Borrowings, current	-16.6%	858	1,029	926	994	773	249
Total current financial liabilities	-9.5%	4,134	4,568	4,283	3,342	2,972	2,630
Provisions, current	7.9%	179	166	143	174	113	97
Current tax liabilities	400%	1.6	0.8	1.3	4.05	2.8	5.86
Total current liabilities	-8.4%	4,579	5,001	4,664	3,780	3,325	2,963
Total liabilities	3.2%	12,004	11,633	9,433	8,683	7,896	7,682
Equity share capital	0%	72	72	72	72	72	72
Non controlling interest	6.5%	441	414	385	369	334	300
Total equity	9.3%	8,653	7,915	7,320	6,878	6,531	6,292
Total equity and liabilities	5.7%	20,657	19,548	16,753	15,561	14,428	13,975

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022
Cash and cash equivalents	-28.4%	233	325	276	254	217	301
Current investments	105.6%	1,432	697	684	562	292	324
Loans, current	-81.2%	22	113	79	80	80	6.08
Total current financial assets	2.9%	3,143	3,054	3,280	3,186	2,820	2,945
Inventories	0%	127	127	119	112	98	124
Current tax assets	-	0	-	-	63	-	10
Total current assets	4.3%	3,518	3,372	3,675	3,506	3,151	3,304
Property, plant and equipment	4.8%	6,239	5,953	5,971	5,355	5,049	5,056
Capital work-in-progress	-0.3%	294	295	172	97	89	43
Goodwill	-	0	0	0	0	0	0
Non-current investments	0.5%	2,479	2,467	1,938	1,938	1,925	1,886
Loans, non-current	19.2%	429	360	245	225	236	315
Total non-current financial assets	2.5%	3,061	2,985	2,361	2,400	2,292	2,296
Total non-current assets	4%	9,854	9,478	8,730	7,994	7,630	7,508
Total assets	4.1%	13,372	12,850	12,405	11,500	10,780	10,812
Borrowings, non-current	-7.6%	1,554	1,681	1,786	1,621	1,520	1,837
Total non-current financial liabilities	-0.3%	2,833	2,841	2,944	2,577	2,225	2,505
Total non-current liabilities	-0.6%	3,197	3,216	3,324	2,949	2,612	2,876
Borrowings, current	12.3%	230	205	170	175	240	132
Total current financial liabilities	-2.2%	1,181	1,207	1,161	1,035	1,062	1,214
Provisions, current	4.1%	128	123	101	123	77	78
Total current liabilities	-0.2%	1,441	1,444	1,370	1,257	1,243	1,400
Total liabilities	-0.5%	4,638	4,659	4,694	4,206	3,856	4,276
Equity share capital	0%	72	72	72	72	72	72
Total equity	6.6%	8,734	8,190	7,711	7,294	6,925	6,536
Total equity and liabilities	4.1%	13,372	12,850	12,405	11,500	10,780	10,812

Cash Flow for Apollo Hospitals Enterprises

Consolidated figures (in Rs. Crores) / View Standalone Data

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	2%	458	449	381	379	-	-
Change in inventories	68.7%	-21	-69.2	42	-175.76	-	-
Depreciation	10.3%	758	687	615	601	-	-
Impairment loss / reversal	-	2	0	0	1.78	-	-
Unrealised forex losses/gains	0%	0.1	0.1	-0.29	-0.55	-	-
Dividend income	-	0.7	0	0	0	-	-
Adjustments for interest income	116.7%	92	43	44	35	-	-
Share-based payments	28.7%	113	88	76	2.56	-	-
Net Cashflows from Operations	10.2%	2,630	2,387	1,759	1,820	-	-
Income taxes paid (refund)	5.8%	494	467	382	204	-	-
Net Cashflows From Operating Activities	11.3%	2,136	1,920	1,377	1,616	-	-
Cashflows used in obtaining control of subsidiaries	-137%	0	3.7	50	100	-	-
Proceeds from sales of PPE	1455.6%	15	1.9	4.07	0	-	-
Purchase of property, plant and equipment	50.7%	1,713	1,137	1,129	657	-	-
Proceeds from sales of investment property	-	0	0	0	5.4	-	-
Proceeds from sales of long-term assets	-100.1%	0	817	0	0	-	-
Purchase of other long-term assets	-100.1%	0	1,171	0	0	-	-
Cash receipts from repayment of advances and loans made to other parties	-50.7%	8.4	16	2.98	11	-	-
Dividends received	-	9.8	0	5.04	0	-	-
Interest received	118.4%	84	39	44	36	-	-
Other inflows (outflows) of cash	-308.3%	-353.8	-85.9	49	-153.66	-	-
Net Cashflows From Investing Activities	-119.9%	-3,380.6	-1,537.1	-856.85	-790.73	-	-
Proceeds from changes in ownership interests in subsidiaries	-	0	0	4.54	0	-	-
Payments from changes in ownership interests in subsidiaries	-89.2%	2.4	14	0	1	-	-
Proceeds from issuing shares	3114.3%	46	2.4	0	0	-	-
Proceeds from borrowings	261.2%	2,551	707	585	426	-	-
Repayments of borrowings	74.3%	442	254	516	712	-	-
Payments of lease liabilities	-	256	0	197	60	-	-
Dividends paid	25.9%	278	221	258	43	-	-
Interest paid	-0.3%	302	303	251	376	-	-
Other inflows (outflows) of cash	-	1	0	0	0	-	-
Net Cashflows from Financing Activities	521.5%	1,317	-311.2	-633.33	-767.7	-	-
Net change in cash and cash eq.	1.4%	73	72	-113.13	57	-	-

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	1.6%	254	250	239	249	-	-
Change in inventories	58.4%	-7.9	-20.4	49	-166.45	-	-
Depreciation	12.6%	449	399	367	400	-	-
Impairment loss / reversal	-	2	0	0	-1.6	-	-
Unrealised forex losses/gains	33.3%	0.4	0.1	-0.23	-0.51	-	-
Dividend income	74.3%	177	102	61	0.39	-	-
Adjustments for interest income	130.6%	84	37	41	19	-	-
Net Cashflows from Operations	38.4%	2,104	1,521	1,548	1,299	-	-
Income taxes paid (refund)	9.7%	362	330	323	98	-	-
Net Cashflows From Operating Activities	46.3%	1,742	1,191	1,224	1,201	-	-
Cashflows used in obtaining control of subsidiaries	-	543	0	0	0	-	-
Proceeds from sales of PPE	12900%	14	1.1	2.33	4.99	-	-
Purchase of property, plant and equipment	38.2%	858	621	396	463	-	-
Proceeds from sales of long-term assets	-100.1%	0	817	0	0	-	-
Purchase of other long-term assets	-100.1%	0	1,180	0	0	-	-
Cash receipts from repayment of advances and loans made to other parties	1133.3%	186	16	16	12	-	-
Dividends received	74.3%	177	102	61	0.39	-	-
Interest received	216.7%	58	19	24	21	-	-
Other inflows (outflows) of cash	-970%	-294.8	35	129	-28.34	-	-
Net Cashflows From Investing Activities	-25.2%	-1,045.7	-835.3	-588.23	-444.6	-	-
Proceeds from borrowings	-100.2%	0	464	150	401	-	-
Repayments of borrowings	-35.8%	173	269	414	658	-	-
Payments of lease liabilities	10.1%	110	100	85	0	-	-
Dividends paid	26.5%	273	216	255	43	-	-
Interest paid	4%	183	176	175	248	-	-
Net Cashflows from Financing Activities	-148.4%	-739.1	-297	-778.62	-637.22	-	-
Net change in cash and cash eq.	-175.7%	-42.9	59	-142.62	119	-	-

What does Apollo Hospitals Enterprises Ltd. do?

Hospital•Healthcare•Mid Cap

Apollo Hospitals Enterprises is a prominent healthcare company based in Chennai, India, with the stock ticker APOLLOHOSP and a market capitalization of Rs. 101,296.5 Crores. The company was established in 1979 and operates both domestically and internationally in various segments of healthcare.

Core Operations
Apollo Hospitals Enterprise Limited, along with its subsidiaries, provides a broad range of healthcare services through several segments, including:

Healthcare Services
Retail Health & Diagnostics
Digital Health & Pharmacy Distribution

Its healthcare facilities deliver primary, secondary, and tertiary care, along with a variety of specialty services. Some key areas of specialization include:

Cardiac sciences
Orthopedics
Oncology
Neurosciences
Emergency services
Robotic surgery
Transplants

Additionally, the company offers numerous other healthcare services in fields like cardiology, neurology, gastroenterology, and more.

Service Offerings
Apollo Hospitals Enterprises also provides:

Project consultancy
Health insurance
Medical education through medical colleges and e-learning platforms
Research services

It manages various healthcare establishments, including pharmacies, clinics, dialysis centers, and specialized health centers. Notably, it engages in bio-banking of tissues and runs Apollo 24/7, a digital health mobile platform.

Financial Performance
The company has reported a trailing twelve months revenue of Rs. 21,313 Crores, demonstrating significant growth of 51.7% over the past three years. Apollo Hospitals Enterprises also returns value to its shareholders, distributing dividends with a yield of 0.35% per year, amounting to Rs. 25 per share in the last 12 months.

Industry Group:Healthcare Services

Employees:83,147

Website:www.apollohospitals.com

APOLLOHOSP - Apollo Hospitals Enterprises Ltd. Share Price

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Risk & Volatility

Investor Care

Financial Health

Technical Indicators

The Bad News

The Good News

Updates from Apollo Hospitals Enterprises

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Apollo Hospitals Enterprises Ltd. do?